EBITDA Summary of Kunming Longjin Pharmaceutical Co., Ltd.

Kunming Longjin Pharmaceutical Co., Ltd.'s latest annual EBITDA in 2023 was -31.19 Million CNY , up 41.01% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd.'s latest quarterly EBITDA in 2024 Q3 was -4.5 Million CNY , down -453.59% from previous quarter.
Kunming Longjin Pharmaceutical Co., Ltd. reported an annual EBITDA of -37.46 Million CNY in 2022, down -122.11% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd. reported an annual EBITDA of 29.92 Million CNY in 2021, up 0.37% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd. reported a quarterly EBITDA of -255.2 Thousand CNY for 2024 Q2, down -36.03% from previous quarter.
Kunming Longjin Pharmaceutical Co., Ltd. reported a quarterly EBITDA of -6.03 Million CNY for 2024 Q1, up 97.83% from previous quarter.

Annual EBITDA Chart of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual EBITDA of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Year	EBITDA	EBITDA Growth
2023	-31.19 Million CNY	41.01%
2022	-37.46 Million CNY	-122.11%
2021	29.92 Million CNY	0.37%
2020	36.86 Million CNY	-38.61%
2019	27.49 Million CNY	129.64%
2018	43.07 Million CNY	-56.6%
2017	66.38 Million CNY	-50.69%
2016	125.3 Million CNY	29.81%
2015	95.61 Million CNY	-3.24%
2014	96.73 Million CNY	10.4%
2013	89.44 Million CNY	-25.56%
2012	126.38 Million CNY	41.22%
2011	85.14 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q3	-4.5 Million CNY	-453.59%
2024 Q2	-255.2 Thousand CNY	-36.03%
2024 Q1	-6.03 Million CNY	97.83%
2023 Q2	-8.05 Million CNY	16.97%
2023 FY	- CNY	41.01%
2023 Q4	543.68 Thousand CNY	102.97%
2023 Q3	-18.3 Million CNY	-127.33%
2023 Q1	-9.69 Million CNY	58.69%
2022 Q2	-2.8 Million CNY	-7571.99%
2022 Q4	-23.47 Million CNY	-97.31%
2022 Q1	37.48 Thousand CNY	103.05%
2022 FY	- CNY	-122.11%
2022 Q3	-11.89 Million CNY	-324.73%
2021 Q4	-1.23 Million CNY	-182.63%
2021 Q1	3.21 Million CNY	-82.92%
2021 Q2	3.45 Million CNY	7.58%
2021 Q3	1.48 Million CNY	-56.93%
2021 FY	- CNY	0.37%
2020 FY	- CNY	-38.61%
2020 Q3	672.7 Thousand CNY	123.49%
2020 Q2	-2.86 Million CNY	60.58%
2020 Q1	-7.26 Million CNY	-117.7%
2020 Q4	18.81 Million CNY	2697.65%
2019 Q2	-8.01 Million CNY	-224.88%
2019 Q1	6.42 Million CNY	403.74%
2019 Q4	41.04 Million CNY	1045.03%
2019 FY	- CNY	129.64%
2019 Q3	-4.34 Million CNY	45.84%
2018 FY	- CNY	-56.6%
2018 Q4	-2.11 Million CNY	-1117.72%
2018 Q3	207.71 Thousand CNY	116.21%
2018 Q2	-1.28 Million CNY	-118.08%
2018 Q1	7.08 Million CNY	-53.29%
2017 Q3	2.88 Million CNY	-67.01%
2017 Q4	15.17 Million CNY	425.65%
2017 Q2	8.75 Million CNY	-30.65%
2017 Q1	12.61 Million CNY	-75.27%
2017 FY	- CNY	-50.69%
2016 Q4	51.01 Million CNY	232.2%
2016 Q3	15.35 Million CNY	-34.24%
2016 Q2	23.35 Million CNY	37.14%
2016 Q1	17.02 Million CNY	-28.85%
2016 FY	- CNY	29.81%
2015 Q4	23.93 Million CNY	51.66%
2015 Q2	16.9 Million CNY	-8.08%
2015 Q3	15.78 Million CNY	-6.63%
2015 FY	- CNY	-3.24%
2015 Q1	18.38 Million CNY	-41.44%
2014 Q1	13.27 Million CNY	0.0%
2014 Q2	18.08 Million CNY	36.23%
2014 Q3	19.94 Million CNY	10.31%
2014 Q4	31.4 Million CNY	57.4%
2014 FY	- CNY	10.4%
2013 FY	- CNY	-25.56%
2012 FY	- CNY	41.22%
2011 FY	- CNY	0.0%

Peer EBITDA Comparison of Kunming Longjin Pharmaceutical Co., Ltd.

Name	EBITDA	EBITDA Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	-141.51 Million CNY	77.954%
Anhui Fengyuan Pharmaceutical Co., Ltd.	388.66 Million CNY	108.027%
Dong-E-E-Jiao Co.,Ltd.	1.53 Billion CNY	102.026%
Livzon Pharmaceutical Group Inc.	3.29 Billion CNY	100.946%
Hainan Haiyao Co., Ltd.	152.19 Million CNY	120.498%
Tus-Pharmaceutical Group Co., Ltd.	62.18 Million CNY	150.171%
Jilin Aodong Pharmaceutical Group Co., Ltd.	1.87 Billion CNY	101.661%
Changchun High-Tech Industries (Group) Inc.	6.09 Billion CNY	100.512%
Apeloa Pharmaceutical Co.,Ltd	1.79 Billion CNY	101.741%
PKU HealthCare Corp.,Ltd.	132.39 Million CNY	123.565%
Chengdu Huasun Technology Group Inc., Ltd.	74.04 Million CNY	142.134%
Dezhan Healthcare Company Limited	219.36 Million CNY	114.222%
Jinling Pharmaceutical Company Limited	249.63 Million CNY	112.498%
Jiuzhitang Co., Ltd.	460.28 Million CNY	106.778%
Huapont Life Sciences Co., Ltd.	2.12 Billion CNY	101.467%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	945.42 Million CNY	103.3%
Shandong Wohua Pharmaceutical Co., Ltd.	87.98 Million CNY	135.456%
Hengkang Medical Group Co., Ltd.	348.09 Million CNY	108.962%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	453.78 Million CNY	106.875%
Qianjiang Yongan Pharmaceutical Co., Ltd.	141.6 Million CNY	122.031%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	124.71 Million CNY	125.014%
Jinhe Biotechnology CO., LTD.	345.42 Million CNY	109.032%
Teyi Pharmaceutical Group Co.,Ltd	369.46 Million CNY	108.444%
Beijing Aosaikang Pharmaceutical Co., Ltd.	-112.74 Million CNY	72.329%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	1.38 Billion CNY	102.247%
Anhui Huangshan Capsule Co., Ltd.	118.18 Million CNY	126.397%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	166.4 Million CNY	118.748%
Zhuhai Rundu Pharmaceutical Co., Ltd.	215.02 Million CNY	114.509%
Huaren Pharmaceutical Co., Ltd.	431.65 Million CNY	107.228%
Tianjin Ringpu Bio-Technology Co.,Ltd.	711.43 Million CNY	104.385%
Shanxi Zhendong Pharmaceutical Co.,Ltd	94.75 Million CNY	132.925%
Fuan Pharmaceutical (Group) Co., Ltd.	528.99 Million CNY	105.898%
Hybio Pharmaceutical Co., Ltd.	-233.61 Million CNY	86.646%
Baotou Dongbao Bio-Tech Co.,Ltd	236.24 Million CNY	113.206%
Hunan Er-Kang Pharmaceutical Co., Ltd	12.02 Million CNY	359.496%
Changjiang Pharmaceutical Group Co., Ltd.	-572.69 Million CNY	94.552%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	383.11 Million CNY	108.143%
Fujian Cosunter Pharmaceutical Co., Ltd.	-190.85 Million CNY	83.654%
Beijing Science Sun Pharmaceutical Co., Ltd.	7.7 Million CNY	505.006%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	87.94 Million CNY	135.472%
Hainan Poly Pharm. Co., Ltd	309.33 Million CNY	110.085%
Jiangxi Synergy Pharmaceutical Co., Ltd.	192.54 Million CNY	116.203%
Wuhan Hiteck Biological Pharma Co.,Ltd	-73.65 Million CNY	57.645%
Shandong Xinhua Pharmaceutical Company Limited	1.09 Billion CNY	102.848%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	435.22 Million CNY	107.168%
PharmaBlock Sciences (Nanjing), Inc.	380.8 Million CNY	108.193%
Jinghua Pharmaceutical Group Co., Ltd.	417.61 Million CNY	107.471%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	-43.99 Million CNY	29.086%
Betta Pharmaceuticals Co., Ltd.	696.09 Million CNY	104.482%
Tibet AIM Pharm. Inc.	50.76 Million CNY	161.459%
Shenzhen Kangtai Biological Products Co., Ltd.	1.29 Billion CNY	102.409%
Shandong Shanda Wit Science and Technology Co., Ltd.	1.39 Billion CNY	102.23%
Pacific Shuanglin Bio-pharmacy Co., LTD	841.98 Million CNY	103.705%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	300.14 Million CNY	110.394%
Xiamen Kingdomway Group Company	588.78 Million CNY	105.299%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	127.06 Million CNY	124.553%
Walvax Biotechnology Co., Ltd.	938.22 Million CNY	103.325%
Sunflower Pharmaceutical Group Co.,Ltd	1.54 Billion CNY	102.017%
Harbin Gloria Pharmaceuticals Co., Ltd	275.28 Million CNY	111.333%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	4.68 Billion CNY	100.665%
Hunan Hansen Pharmaceutical Co., Ltd.	280.66 Million CNY	111.116%
Changzhou Qianhong Biopharma CO.,LTD	278.66 Million CNY	111.195%
Shenzhen Weiguang Biological Products Co., Ltd.	350.21 Million CNY	108.908%
Honz Pharmaceutical Co., Ltd.	133.53 Million CNY	123.363%
Northeast Pharmaceutical Group Co., Ltd.	1.19 Billion CNY	102.607%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	217.47 Million CNY	114.345%
Guizhou Xinbang Pharmaceutical Co., Ltd.	654.01 Million CNY	104.77%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	477.37 Million CNY	106.535%
Zhejiang Yatai Pharmaceutical Co., Ltd.	76.31 Million CNY	140.881%
Zhejiang NHU Company Ltd.	5.24 Billion CNY	100.594%
ApicHope Pharmaceutical Co., Ltd	464.04 Million CNY	106.723%
Shanghai Kaibao Pharmaceutical CO.,Ltd	375.33 Million CNY	108.312%
Beijing SL Pharmaceutical Co., Ltd.	610.29 Million CNY	105.112%
Yunnan Baiyao Group Co.,Ltd	5.2 Billion CNY	100.599%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	127.72 Million CNY	124.427%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	228.9 Million CNY	113.629%
Guangdong Lifestrong Pharmacy Co., Ltd.	50.95 Million CNY	161.22%
Huadong Medicine Co., Ltd	4.61 Billion CNY	100.676%
Jiangsu Nhwa Pharmaceutical Co., LTD	1.33 Billion CNY	102.33%
Harbin Medisan Pharmaceutical Co., Ltd.	183.66 Million CNY	116.986%
LanZhou Foci Pharmaceutical Co.,Ltd.	135.36 Million CNY	123.046%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	1.04 Billion CNY	102.98%
Beijing Beilu Pharmaceutical Co., Ltd	36.44 Million CNY	185.601%
Nanjing Hicin Pharmaceutical Co., Ltd.	97 Million CNY	132.162%
Renhe Pharmacy Co., Ltd.	1.05 Billion CNY	102.969%
Chongqing Pharscin Pharmaceutical Co., Ltd.	125.84 Million CNY	124.79%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	863.95 Million CNY	103.611%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	-320.08 Million CNY	90.253%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	-298.6 Million CNY	89.552%

Global Stocks Search

Kunming Longjin Pharmaceutical Co., Ltd. (002750.SZ)

EBITDA Summary of Kunming Longjin Pharmaceutical Co., Ltd.

Annual EBITDA Chart of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual EBITDA of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Peer EBITDA Comparison of Kunming Longjin Pharmaceutical Co., Ltd.